Félix Bermejo-Pareja1,2, Israel Contador3, Rocío Trincado2, David Lora4, Álvaro Sánchez-Ferro5,6, Alex J Mitchell7, Elina Boycheva4, Alejandro Herrero8, Jesús Hernández-Gallego2,8,9, Sara Llamas4, Alberto Villarejo Galende2,8, Julián Benito-León2,8. 1. Consultant Neurologist of the Clinical Research Unit (Imas12), University Hospital "12 de Octubre", Madrid, Spain. 2. Ciberned, Carlos III Research Institute, Madrid, Spain. 3. Department of Basic Psychology, Psychobiology and Methodology of Behavioral Sciences, University of Salamanca, Spain. 4. Clinical Research Unit (Imas12- CIBERESP), University Hospital "12 de Octubre", Madrid, Spain. 5. Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA. 6. Centro Integral de Neurociencias A.C., Fundación Hospitales de Madrid, Móstoles, Madrid, Spain. 7. Department of Cancer and Molecular Medicine, University of Leicester, UK. 8. Department of Neurology, University Hospital "12 de Octubre", Madrid, Spain. 9. Department of Medicine, Complutense University (UCM), Madrid, Spain.
Abstract
BACKGROUND: The predictive value of diverse subtypes of mild cognitive impairment (MCI) for dementia and death is highly variable. OBJECTIVE: To compare the predictive value of several MCI subtypes in progression to dementia and/or mortality in the NEDICES (Neurological Disorders in Central Spain) elderly cohort. METHODS: Retrospect algorithmic MCI subgroups were established in a non-dementia baseline NEDICES cohort using Spanish adaptations of the original Mini-Mental State Examination (MMSE-37) and Pfeffer's Functional Activities Questionnaire (Pfeffer-11). The presence of MCI was defined according two cognitive criteria: using two cut-offs points on the total MMSE-37 score. Five cognitive domains were used to establish the MCI subtypes. Functional capacity (Pfeffer-11) was preserved or minimally impaired in all MCI participants. The incident dementia diagnoses were established by specialists and the mortality data obtained from Spanish official registries. RESULTS: 3,411 participants without dementia were assessed in 1994-5. The baseline prevalence of MCI varied according to the MCI definition (4.3%-31.8%). The follow-up was a mean of 3.2 years (1997-8). The dementia incidence varied between 14.9 and 71.8 per 1,000/person-years. The dementia conversion rate was increased in almost all MCI subgroups (p > 0.01), and mortality rate was raised only in four MCI subtypes. The amnestic-multi-domain MCI (aMd-MCI) had the best dementia predictive accuracy (highest positive likelihood ratio and highest clinical utility when negative). CONCLUSIONS: Those with aMd-MCI were at greatest risk of progression to dementia, as in other surveys and might be explored with increased attention in MCI research and in dementia preventive trials.
BACKGROUND: The predictive value of diverse subtypes of mild cognitive impairment (MCI) for dementia and death is highly variable. OBJECTIVE: To compare the predictive value of several MCI subtypes in progression to dementia and/or mortality in the NEDICES (Neurological Disorders in Central Spain) elderly cohort. METHODS: Retrospect algorithmic MCI subgroups were established in a non-dementia baseline NEDICES cohort using Spanish adaptations of the original Mini-Mental State Examination (MMSE-37) and Pfeffer's Functional Activities Questionnaire (Pfeffer-11). The presence of MCI was defined according two cognitive criteria: using two cut-offs points on the total MMSE-37 score. Five cognitive domains were used to establish the MCI subtypes. Functional capacity (Pfeffer-11) was preserved or minimally impaired in all MCI participants. The incident dementia diagnoses were established by specialists and the mortality data obtained from Spanish official registries. RESULTS: 3,411 participants without dementia were assessed in 1994-5. The baseline prevalence of MCI varied according to the MCI definition (4.3%-31.8%). The follow-up was a mean of 3.2 years (1997-8). The dementia incidence varied between 14.9 and 71.8 per 1,000/person-years. The dementia conversion rate was increased in almost all MCI subgroups (p > 0.01), and mortality rate was raised only in four MCI subtypes. The amnestic-multi-domain MCI (aMd-MCI) had the best dementia predictive accuracy (highest positive likelihood ratio and highest clinical utility when negative). CONCLUSIONS: Those with aMd-MCI were at greatest risk of progression to dementia, as in other surveys and might be explored with increased attention in MCI research and in dementia preventive trials.
Authors: Sanne S Mooldijk; Amber Yaqub; Frank J Wolters; Silvan Licher; Peter J Koudstaal; M Kamran Ikram; M Arfan Ikram Journal: J Am Geriatr Soc Date: 2021-10-18 Impact factor: 7.538
Authors: Zachary A Marcum; Jordana B Cohen; Chong Zhang; Catherine G Derington; Tom H Greene; Lama Ghazi; Jennifer S Herrick; Jordan B King; Alfred K Cheung; Nick Bryan; Mark A Supiano; Joshua A Sonnen; William S Weintraub; Jeff Williamson; Nicholas M Pajewski; Adam P Bress Journal: JAMA Netw Open Date: 2022-01-04
Authors: Helena S Moreira; Ana Sofia Costa; Álvaro Machado; São Luís Castro; César F Lima; Selene G Vicente Journal: PLoS One Date: 2019-09-10 Impact factor: 3.240
Authors: Félix Bermejo-Pareja; Teodoro Del Ser; Meritxell Valentí; Mónica de la Fuente; Fernando Bartolome; Eva Carro Journal: Alzheimers Dement Date: 2020-06-16 Impact factor: 21.566
Authors: Nikki Delgado; Daniella Iglesias Hernandez; Keith Radler; Edward D Huey; Stephanie Cosentino; Elan Louis Journal: J Neurol Sci Date: 2021-07-02 Impact factor: 4.553